Nano-X Imaging (NNOX) Free Cash Flow (2021 - 2026)
Nano-X Imaging (NNOX) posted quarterly Free Cash Flow of -$12.2 million for Q1 2026, down 24.26% year-on-year from -$16.1 million in Q1 2025, and up 11.14% on a QoQ basis from -$13.7 million in Q4 2025.
Nano-X Imaging (NNOX) Free Cash Flow (2021 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Free Cash Flow for 6 consecutive years, with -$12.2 million the latest figure, recorded in Q1 2026.
- Quarterly Free Cash Flow fell 24.26% year-over-year to -$12.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$43.1 million (down 8.23% YoY) and the FY2025 annual result came in at -$40.8 million, down 3.55% from the prior year.
- Free Cash Flow climbed to -$12.2 million in Q1 2026 per NNOX's latest filing, from -$13.7 million in the prior quarter.
- Over the last five years, Free Cash Flow for NNOX reached as high as -$6.0 million in Q3 2022 and fell as low as -$22.8 million in Q4 2022.
- A 5-year average of -$10.9 million and a median of -$9.3 million in 2024 frame the typical range for Free Cash Flow.
- The largest YoY upside for Free Cash Flow was 61.79% in 2022 against a maximum downside of 1196.21% in 2022.
- Year by year, Free Cash Flow stood at -$22.8 million in 2022, then advanced by 18.51% to -$18.6 million in 2023, then grew by 19.16% to -$15.0 million in 2024, then grew by 8.82% to -$13.7 million in 2025, then climbed by 11.14% to -$12.2 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$12.2 million, -$13.7 million, and -$9.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | -12.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.18 Mn |
| Mar 31, 2026 | -12.18 Mn |
| Dec 31, 2025 | -13.70 Mn |
| Dec 31, 2025 | -13.70 Mn |
| Sep 30, 2025 | -9.00 Mn |
| Sep 30, 2025 | -9.00 Mn |
| Jun 30, 2025 | -8.26 Mn |
| Jun 30, 2025 | -8.26 Mn |
| Mar 31, 2025 | -9.80 Mn |
| Mar 31, 2025 | -9.80 Mn |
| Dec 31, 2024 | -15.03 Mn |
| Dec 31, 2024 | -15.03 Mn |
| Sep 30, 2024 | -7.39 Mn |
| Sep 30, 2024 | -7.39 Mn |
| Jun 30, 2024 | -7.64 Mn |
| Jun 30, 2024 | -7.64 Mn |
| Mar 31, 2024 | -9.30 Mn |
| Mar 31, 2024 | -9.30 Mn |
| Dec 31, 2023 | -18.59 Mn |
| Dec 31, 2023 | -18.59 Mn |